Clinical Trial

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with combination chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with no radiation therapy following chemotherapy in treating patients with stage III or stage IV Hodgkin's disease.
Protocol Amendment History 23 amendments
This ClinicalTrials.gov record has been amended 23 times since 2005-06-23; most recent amendment 2025-08-04.
Trial Details
NCT Number NCT00002462
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Conditions Lymphoma
Enrollment 615 participants
Start Date 1989-09
Primary Completion 2000-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-05